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ABSTRACT: Waterborne viruses can exhibit resistance to common water
disinfectants, yet the mechanisms that allow them to tolerate disinfection are
poorly understood. Here, we generated echovirus 11 (E11) with resistance to
chlorine dioxide (ClO2) by experimental evolution, and we assessed the
associated genotypic and phenotypic traits. ClO2 resistance emerged after
E11 populations were repeatedly reduced (either by ClO2-exposure or by
dilution) and then regrown in cell culture. The resistance was linked to an
improved capacity of E11 to bind to its host cells, which was further
attributed to two potential causes: ﬁrst, the resistant E11 populations
possessed mutations that caused amino acid substitutions from ClO2-labile to
ClO2-stable residues in the viral proteins, which likely increased the chemical
stability of the capsid toward ClO2. Second, resistant E11 mutants exhibited
the capacity to utilize alternative cell receptors for host binding. Interestingly,
the emergence of ClO2 resistance resulted in an enhanced replicative ﬁtness compared to the less resistant starting population.
Overall this study contributes to a better understanding of the mechanism underlying disinfection resistance in waterborne
viruses, and processes that drive resistance development.
■ INTRODUCTION
A disinfection step in the water treatment processes constitutes
an essential barrier to the transmission of waterborne
pathogens. A challenge arises when, despite disinfection,
pathogens are not adequately inactivated during water
treatment. Incomplete disinfection may result from many
diﬀerent factors, including short-circuiting in the disinfection
tank,1 shielding of the pathogens by particles,2,3 or a high
disinfectant demand of the matrix.4 Alternatively, the ability to
resist disinfection may be a pathogen-inherent trait that may be
selected for during the disinfection process. In support of this
notion, several studies have reported on the presence of
chlorine-resistant microbes in disinfected drinking water.5−8 To
date, however, information regarding the emergence of
pathogens resistant to disinfectants remains scarce.
Compared to other pathogens, single-stranded (ss) RNA
viruses may be particularly prone to develop disinfection
resistance. Because they do not possess proof-reading
mechanisms,9 ssRNA viruses exhibit high mutation rates,10−12
which enable them to evolve and adapt rapidly to new
environments. For example, populations of ssRNA viruses have
been reported to readily adapt to stressors such as heat or free
chlorine.13,14
In previous work, we determined that bacteriophage MS2, a
commonly used surrogate for human enteric viruses, can evolve
resistance toward chlorine dioxide (ClO2), and we described
the associated resistance mechanisms.15 Herein, we explore if
similar resistance development can also occur in a human
pathogenic virus, echovirus 11 (E11). Echovirus, together with
coxsackievirus, rhinovirus, poliovirus and enterovirus, belongs
to the Enterovirus genus of the family Picornaviridae. Infective
enteroviruses are commonly present in raw wastewater up to
103 plaque forming units/L,1 and there is ample evidence
demonstrating that certain enteroviruses can withstand waste-
water treatment.16−19 Moreover, enteroviruses were also
detected in ﬁnished drinking water and drinking water
sources.20−23 This prevalence of enteroviruses is problematic,
because infection by human enteroviruses can lead to serious
illness, especially in infants and in immunocompromised
individuals.
The structure of the diﬀerent enteroviruses, including
echoviruses, is relatively simple and well-investigated, whereas
there are still gaps in the understanding of their complex
replication cycle.24 In brief, enteroviruses are naked, icosahedral
viruses with a diameter of approximately 30 nm and a single-
stranded, positive sense RNA genome of approximately 7400
nucleotides. The main building block of the enterovirus capsid
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is a protomer that contains viral proteins (VP) 1−4, whereby
the structural diﬀerences in the loops of VP1-VP3 give each
type of enterovirus its distinct morphology and antigenicity.25
The enterovirus surface has an uneven topography, with a
plateau at the 5-fold axis surrounded by a deep depression
(canyon) and another high point at the 3-fold axis (Figure 1).
As a primary host cell receptor, echovirus 11 uses cell surface
protein decay-accelerating factor (DAF or CD55).26 To trigger
entry into the host, the virus must additionally interact with
secondary or coreceptors, such as β2-microglobulin.27−29 Host
entry can occur by diﬀerent endocytic mechanisms, including
clathrin- and caveolin-mediated endocytosis, as well as
macropinocytosis.30−33 After entry, membrane vesicles carrying
viruses move in the cytoplasm with the aid of microtubules or
actin to the endosome where uncoating occurs. The genome is
then translated in the cytoplasm into a single polyprotein which
is split into four structural proteins (VP1−4) and seven
nonstructural proteins (2Apro, 2B, 2C, 3A, 3B, 3Cpro, and
3Dpol).34 The subsequent genome replication occurs in double
membrane vesicles in the cytoplasm. Finally, new virions are
released from the cell via lysis.
During disinfection, viruses are damaged such that one or
several steps in their replication cycle can no longer be
completed, resulting in inactivation. ClO2 is a highly eﬀective
disinfectant which has been shown to inactivate a broad range
of viruses including feline calicivirus, hepatitis A virus,
coxsackievirus, adenovirus, poliovirus and rotavirus.35−38 The
virucidal mechanism of ClO2 appears to diﬀer between viruses:
in bacteriophage MS2, the mode of action of ClO2 mainly
involves the degradation of the viral proteins, which in turn
impairs the viral binding to host cells.39 In enteroviruses, in
contrast, ClO2 has been proposed to act on the viral genome.
Speciﬁcally, it was suggested that inactivation of poliovirus,
enterovirus 71 and hepatitis A virus by ClO2 were caused by
damage in the 5′ noncoding region.40−43 It was, however, not
resolved if genome damage fully accounts for the observed
infectivity loss, or if protein damage also contributes to
inactivation. For example, Li et al. suggested that the
destruction of antigenicity was partly responsible for the
inactivation of hepatitis A virus.40 Similarly, Simonet and
Gantzer observed a discrepancy between poliovirus infectivity
loss obtained by cell culture and genome decay measured by
real-time PCR, suggesting an important role of protein damage
in inactivation.42 In contrast, Alvarez and O’Brien also observed
reaction of ClO2 with the capsid of poliovirus, but reported that
the critical target was viral RNA.44 Given the range of viral
components and functions targeted by ClO2, ClO2-resistance in
echovirus may thus result from modiﬁcation to any of the major
viral functions (host binding, host entry or genome
replication).
The objectives of this study were to determine genotypic and
phenotypic characteristics associated with E11 resistance to
ClO2. Speciﬁcally, we ﬁrst developed E11 with resistance to
ClO2 by experimental evolution and identiﬁed the accompany-
ing genotypic modiﬁcations. We then assessed which viral
functions are altered in resistant viruses and evaluated the cost
of acquiring resistance with respect to the virus’ replicative
ﬁtness.
■ EXPERIMENTAL SECTION
Cells and Viruses. Details pertaining to the culturing,
puriﬁcation and enumeration of E11 and associated host cells
are given in the Supporting Information (SI).
Chlorine Dioxide Production. Concentrated ClO2 was
produced as described previously15 and was stored in the
refrigerator at 4 °C. ClO2 working solutions were prepared in
phosphate-buﬀered saline (PBS; 5 mM Na2HPO4 (99%,
Acros), 10 mM NaCl (99.5% (Acros), pH 7.4) immediately
prior to each experiment.
Experimental Evolution Assays. Experimental evolution
assays to produce ClO2-resistant E11 were conducted
analogously to those described previously for MS2 coliphage.15
In brief, a commercially available starting population of E11,
hereafter referred to as “wild-type” (WT) was subjected to
repeated cycles of ClO2 exposure. Following inactivation, the
remaining infective viruses were concentrated, washed with
PBS, and were spiked onto a monolayer of BGMK cells. The
multiplicity of infection (MOI) was less than 0.005
(approximately 102−104 viruses, quantiﬁed as most probable
number cytopathogenic units (MPNCU), per 2.6 × 106 cells).
After incubation at 37 °C, the regrown populations were
puriﬁed as described in the SI, and re-exposed to ClO2. The
disinfection-regrowth cycles were conducted until cycle 10,
when the evolved population was divided and two experimental
evolution assays were continued in parallel with ten more
cycles. After a total of 20 cycles, an approximately 50%
reduction in inactivation rate constant by ClO2 was achieved
(see below) and the experiment was halted. The two resulting
populations are named EA and EB hereafter, where E stands for
“exposed to ClO2”. The ClO2 concentration used was 0.5 mg/L
in the early cycles, and incrementally increased to 4 mg/L at
cycle 15 and following.
Our previous work on MS2 revealed that resistance to ClO2
could emerge if MS2 populations were repeatedly subjected to
sharp reduction in size (bottleneck event) and then regrown,
whereby the cause of the bottleneck (ClO2 or dilution) was
irrelevant.15 We therefore included two E11 populations in this
study, which were repeatedly subjected to bottleneck events
induced by dilution rather than ClO2 exposure, followed by
regrowth in cell culture. Speciﬁcally, after each regrowth step,
the populations were diluted and approximately 102−103
MPNCU were passed to the next cycle. The dilution-regrowth
cycles were continued for 10 cycles, at which point a
comparable extent of resistance as in populations EA and EB
Figure 1. Echovirus 11 capsid topography and protein protomer. Left:
Surface rendering of the half capsid of an echovirus 11 with radial
coloring showing the relative distance from the center of the particle.
Darker regions are closer to the particle center. The 2-fold, 3-fold, and
5-fold symmetry axes are labeled in red. The location of one protomer
is indicated in yellow. The image was produced in Chimera based on
PDB entry 1H8T.75 Right: The protomer composed of VP1 (blue),
VP2 (yellow), VP3 (red), and VP4 (green) with the symmetry axes
labeled. The canyon, which is a deep depression surrounding the 5-
fold axis is formed by VP1 and VP3, and is recognized as a receptor-
binding site for some other enteroviruses.25 The structure was
visualized by Swiss-PdbViewer based on PDB entry 1H8T.75
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was achieved. The two resulting populations are henceforth
named NEA and NEB, where NE stands for “non-exposed”.
Kinetic Inactivation Experiments with ClO2. To
monitor the emergence of ClO2 resistance, the rate constants
for the inactivation of the evolved E11 populations by ClO2
were compared to those of the wild-type. To this end, E11 was
spiked into beakers containing 2 mL PBS to a starting
concentration of approximately 108 MPNCU/mL. The reactors
were then spiked with a one-time dose of ClO2 to yield an
initial concentration of 1 mg/L. All the experiments were
conducted in 10 mL beakers positioned on ice, and reactors
were continuously stirred. Samples were taken periodically and
mixed immediately with PBS containing 10% w/v sodium
thiosulfate (98%, Sigma-Aldrich) to quench the residual ClO2.
To derive kinetic parameters, inactivation data of replicate
experiments were pooled and ﬁtted to the modiﬁed Hom
model, which accounts for the fact that the ClO2 concentration
decayed over time:45
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Here N and N0 are the infective virus concentrations at times t
and 0 respectively; C0 is the initial ClO2 concentration, kClO2
the Hom inactivation rate constant [(mg/L)−nmin−m], m is a
parameter that describes the deviation from ﬁrst-order, n is the
coeﬃcient of dilution, and kd [min
−1] is the decay rate constant
of ClO2. The concentration of ClO2 (C) was measured
throughout the experiments by mixing sample aliquots at a 1:2
molar ratio with chlorophenol red (Sigma) and spectrophoto-
metrically measuring its discoloration.46 The value of kd (0.11−
1.10 min−1) was then determined from a ﬁrst-order ﬁt of the
ClO2 concentration versus time:
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As speciﬁed previously,15 parameters m and n were treated as
constant parameters across all experiments and were
determined for each virus by simultaneously ﬁtting all the
experiments conducted while varying only kClO2. The values of
m and n correspond to 0.30 and 0.46 respectively.
For ease of readability, inactivation data is presented as plots
of log10 inactivation ( ( )log NN10 0 ) versus ClO2 exposure. Hereby
the exposure corresponds to the (time-dependent) concen-
tration of ClO2, integrated over the exposure time t:
∫=osure CdtClO exp t2
0 (4)
Viral Genome Characterization. The whole genomes of
virus populations of interest were interrogated by Next
Generation Sequencing (NGS). The NGS data were further
used to identify mutation clusters. In addition, the ratios of
nonsynonymous or synonymous segregating sites (pN/pS)
were calculated for each protein-coding gene of the evolved
populations, in order to characterize the genomic response of
diﬀerent proteins to the imposed experimental conditions.
BLAST analysis was performed using Geneious (Version
10.0.8) to compare the genome sequences of the evolved
populations with published sequences. Experimental and
computational details pertaining to the genome characterization
are given in the SI.
Quantiﬁcation of Host Binding. The ability of E11 to
bind to host cells was assessed either by quantifying the host
cells exhibiting attached viruses, or by enumerating the viruses
bound to cells.
To measure the number of cells with bound viruses, a ﬂow
cytometry assay was modiﬁed from Triantaﬁlou et al.47
Speciﬁcally, cells were harvested using 1:10 diluted citric saline
solution (concentrated solution: 1.35 M KCl (Acros) and 0.15
M NaC6H7O7 (Sigma)) and ﬁxed in ﬁxing buﬀer (4%
paraformaldehyde; AlfaAesar) for 10 min on ice, followed by
washing with PBS supplemented with 30 mM glycine (Sigma)
and blocking buﬀer (PBS with 1% bovine serum albumin
(Sigma)). Cells were incubated in 1 mL blocking buﬀer for 30
min at room temperature, and were then counted to ensure the
presence of roughly 106 cells/mL. E11 diluted in binding buﬀer
(PBS supplemented with 2 mM CaCl2 (99+%, Acros) and 1
mM MgCl2 (99%, Acros) was added to the cells and incubated
for 1 h at room temperature. Care was taken to use the same
MOI for samples that were directly compared. After incubation,
unbound viruses were removed by washing three times in
binding buﬀer. Cells were then sequentially incubated on a
rotator with a primary anti-E11 mouse monoclonal antibody
(LSBio) and secondary goat antimouse antibody conjugated
with FITC (Sigma), at a concentration of 5 μg/mL each.
Between each incubation with antibody, cells were washed
three times with blocking buﬀer. Staining was measured using a
CyFlowSL ﬂow cytometer (Partec) and analyzed by FlowMax
(see SI, Figure S1). To test the role of the DAF receptor in host
binding, cells were incubated with rabbit monoclonal anti-DAF
antibody conjugated with APC (Biorbyt) at a concentration of
20 μg/mL to block the receptors prior to exposure to the virus.
To quantify the number of viruses attached to cells, an
approach based on cell culturing was used. Viruses were
incubated with cell monolayers on 6-well plates for 1 h on ice.
The cell monolayer was then washed with PBS to remove any
unbound virus. Trypsin-EDTA (Gibco, Frederick, MD)
solution was used to detach the cell monolayer. Cells were
then subjected to chloroform treatment as described in the
virus production procedure (SI) and the virus was harvested
and quantiﬁed by quantitative real-time PCR (qRT-PCR) as
described in the SI.
Assessment of Receptors and Entry Routes Used. To
identify the key attachment and entry routes, viral growth
curves of the populations of interest were compared under
three conditions: standard growth conditions in BGMK cells;
growth on cells pretreated with anti-DAF antibody to block the
primary cell receptor; and growth of viruses in the presence of
drugs that inhibit diﬀerent attachment or entry routes. Details
pertaining to each condition are given in the SI.
Competitive Fitness. The replicative ﬁtness of the mutants
was assessed in competition with the wild-type. Speciﬁcally, a
mutant population (EA or NEA) was coinfected with WT onto
BGMK, A549, Vero or Caco-2 cell lines at a 1:1 ratio. To
identify the virus with the greater ﬁtness, the WT:mutant ratio
was reassessed 72 h post infection. To do so, genome segments
5061−5354 and 6895−7193 were Sanger sequenced using
primer sets 20 and 27 (SI, Table S1) for EA and NEA,
respectively (see SI for details). These two segments contain
one mutation each (T5203C and A6989G) that is present in
<2% of the WT but in >95% of the mutant, and thus allow to
distinguish between WT and mutant. The sequencing peak
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height of WT and the mutants at the two mutation sites was
used to evaluate the WT:mutant ratio at the time of coinfection
and 72 h post infection. While this approach is only
semiquantitative, it allowed us to determine which virus
prevailed in direct competition.
Statistical Analysis. The goodness-of-ﬁt of the data was
evaluated based on the coeﬃcient of determination (R2)
determined by GraphPad Prism (Version 6.01, 2012). Like-
lihood ratio (LR) test48 was applied to determine if the
inactivation kinetics signiﬁcantly diﬀered between two or more
viral populations, with the threshold p-value for statistical
signiﬁcance, determined by Chi-squared test, set to 0.05.
Unpaired t test or regular one-way ANOVA was applied to
compare all other parameters between populations.
Accession Numbers. Genome sequence obtained by NGS
of the WT, EA, EB, NEA and NEB populations have been
deposited in NCBI’s BioSample database with the accession
numbers SAMN07510747 to SAMN07510751.
■ RESULTS AND DISCUSSION
Emergence of Resistance. Pooled inactivation curves of
WT and the resistant (or mutant) populations E and NE are
shown in Figure 2A. The curves exhibit a tailing feature that is
frequently observed for virus inactivation by ClO2.
36,41,49 This
behavior is well-captured by the modiﬁed Hom model (eq 1).
Despite some scatter in the data, it is apparent from Figure 2A
that both the exposed populations and the nonexposed
echovirus populations were more resistant to ClO2 than WT.
Figure 2B shows the inactivation rate constants of WT and all
evolved populations. ClO2-resistance in the evolved popula-
tions is manifested in values of kClO2 that were signiﬁcantly
smaller than that of WT (p < 0.01 for all four populations). The
kClO2 of the evolved populations ranged from 33% to 60% of
that of WT.
Similar to our previous observation on the emergence of
ClO2 resistance in MS2,
15 viruses evolved from both ClO2-
exposed and nonexposed evolution pathways became resistant
to ClO2. This ﬁnding may be explained by two eﬀects: ﬁrst, it is
known that serial passages of viruses in cells can lead to an
increased replicative ﬁtness as a result of cell culture
adaptation.50,51 Repeated viral regrowth in our experimental
setup could thus intensify the selection of adapted viruses with
a replicative advantage. Second, the repeated bottleneck events
likely promoted those E11 variants that most successfully
regrew from low MOI, and the traits that allow for eﬃcient
regrowth may also be essential for ClO2 resistance. Overall, we
thus suggest that, analogous to ClO2 resistance in MS2, it was
repeated regrowth from a population bottleneck that induced
ClO2 resistance in E11. In contrast, we are not able to identify
the role of ClO2 exposure as a sole or additional driving force
that induced the resistance.
Genotypic Features of Resistant Populations. Next
generation sequencing was utilized to identify the genomic
changes related to resistance. Mutations in the evolved ﬁnal
populations were identiﬁed with reference to the WT
consensus sequence and are shown in Table 1. This table
includes all mutations that changed from minor to major alleles,
as well as those that changed from major (50−98%) to ﬁxed
(>99%) alleles. The identiﬁed mutations were located in both
Figure 2. Disinfection kinetics of E11 by ClO2. (A) Inactivation data
of E11 WT (black circles), E (purple triangles) and NE (green
squares) are shown as ﬁlled symbols. Solid lines indicate the
corresponding ﬁts to the modiﬁed Hom Model (eq 1). (B)
Inactivation rate constants kClO2 of the wild-type and the four evolved
populations EA, EB, NEA, and NEB at their ﬁnal passages.
Table 1. Heat Map of the Frequency of Alleles That Changed
from Minor to Major or from Major to Fixed in the Evolved
Populations EA, EB, NEA, and NEB, Compared to the Wild-
Type WT, As Identiﬁed by Next Generation Sequencinga
aThe location of the mutation, and the resulting change in nucleotide
and amino acid are listed. Mutations that reached ﬁxation (≥99%) are
indicated by bold fonts. bThese mutations on the structural protein
VP1 caused an amino acid substitution from ClO2-reactive to
nonreactive ones. cAt these locations, major alleles in WT became
ﬁxed in some evolved populations. The change from WT to evolved
population thus concerns the mutation of the minor WT allele to the
major one. In these cases, the notation therefore indicates the minor
allele (or amino acid) of the WT on the left, and the major or ﬁxed
one on the right. dAt this location, EB has 50% C and 50% T.
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structural and nonstructural proteins, while most nonsynon-
ymous mutations were in the structural proteins. Both
synonymous and nonsynonymous mutations can cause
phenotypic changes in enteroviruses, but these eﬀects are
more common for nonsynonymous mutations.52 Therefore,
nonsynonymous mutations are more likely to be involved in
adaptation to disinfection.
The ﬁnal E and NE populations exhibited very distinct sets of
mutations, despite their similar resistance to ClO2 (Figure 2).
The mutations found in the E but not NE populations may be a
result of adaptation of E to ClO2. Alternatively, the diﬀerences
in mutational spectra may stem from the diﬀerent numbers of
experimental evolution passages experienced by the two
population types (10 for NE versus 20 for E). Within each
population type, the replicates had similar genotypes. Replicates
EA and EB shared most of their mutations, including nine
synonymous changes. Populations NEA and NEB exhibited the
same consensus sequence.
Of the mutations listed in Table 1, several emerged in
clusters (see SI, Table S2 and accompanying text for details).
The clustering of mutations suggests that while certain allele
frequencies may be rising owing to genetic hitchhiking,53 one
or more mutations in each cluster are likely a result of positive
selection.54 Yet, a comparison of the ratio of nonsynonymous
to synonymous polymorphism (pN/pS) across proteins yielded
pN/pS ratios <1 for all proteins and virus populations (SI Table
S3), indicating strong purifying selection. This observation is
consistent with the small number of mutations being ﬁxed
during the experiment.
Role of Host Binding in Inactivation and Resistance.
Resistance to ClO2 implies that the majority of viruses in the
population can execute their essential functions−host binding,
entry, replication and assembly−despite exposure to ClO2. For
wild-type MS2, we previously demonstrated that ClO2 impairs
host binding,39 while ClO2-resistant MS2 are able to better
maintain host binding in the presence of ClO2.
15 It is
conceivable that a similar mechanism underlies echovirus
resistance to ClO2. This notion is supported by our ﬁnding that
positively selected mutations mainly occurred in the structural
proteins (Table 1) which are related to host attachment and
entry.
To test the role of host binding in resistance development,
we ﬁrst conﬁrmed that the inactivation of E11 WT coincides
with a loss in host binding (Figure 3A). We then compared
host binding in the presence of ClO2 between the WT and that
of the evolved populations (Figure 3B). As observed for MS2,
the eﬀect of ClO2 on host binding was diminished for E and
NE at any given ClO2 exposure. Overall, the two evolved
populations exhibited lower binding loss rates than WT (p-
values of 0.025 and 0.020 respectively). This ﬁnding suggests
that an enhanced binding capacity of echovirus to the host cells
contributes to the observed ClO2 resistance.
Protein Modiﬁcations Associated with Enhanced Host
Binding. The diﬀerences in host binding between mutants and
WT could be tentatively linked to the genetic and associated
protein modiﬁcations in the evolved populations. For this
analysis, we relied on literature reports of the same or similar
mutations, as well as on chemical and structural considerations.
E11 uses DAF as the main cellular receptor,26 and various
binding sites on E11 to DAF have been suggested. Stuart et al.
postulated that the binding site is located close to 5-fold axis
(Figure 1),55 whereas Rezaikin et al. argued that it is near the 2-
fold axis, as encountered in many other enteroviruses.56 In
addition, both studies suggested the presence of an alternative
unidentiﬁed coreceptor which binds in the canyon region, a
depression surrounding the 5-fold axis formed by VP1 and VP3
(Figure 1).
Of the 14 nonsynonymous mutations listed in the mutant
populations, 11 are located on structural proteins VP1, VP2,
and VP3 (depicted in SI Figure S4). In the mutant E
populations, a series of mutations (S131N, P129Q, K126R,
T235I, and M238V) line the canyon wall on VP1 (SI Figure
S4). The cellular receptor DAF binds away from the canyon
across VP2 and VP3. As such, it is unlikely to be aﬀected by the
mutations on the canyon wall. However, the interaction
between E11 and DAF have a low aﬃnity while the interaction
between poliovirus and rhinovirus with their corresponding
canyon-binding receptors PVR and ICAM-1 are higher.57−59 It
is thus conceivable that the series of VP1 mutations along the
canyon wall enhances the interaction between the virus and an
unknown canyon-binding (co)receptor and strengthen virus
binding in the canyon relative to DAF. This, in essence, would
constitute a shift in the main cellular receptor used by ClO2-
resistant echovirus. Previous studies conﬁrm that echovirus can
use the canyon region for receptor binding. For example,
echovirus 1 uses the canyon region for binding to the functional
domain α2I of human α2β1.31
A shift in the cellular receptors is further supported by
comparing the mutations found herein with those previously
found in variants of E11 with altered cell receptor use. Stuart et
al. identiﬁed a number of mutations present in a variant of E11
that was able to infect cells in a DAF-independent manner.55
Speciﬁcally, the DAF-independent echovirus had mutations in
location 139 on VP2, alongside seven others including position
Figure 3. Eﬀect of ClO2 on virus binding to host cells. (A) Infectivity loss (open circles) and binding loss (ﬁlled circles) of WT as a function of ClO2
exposure. N/N0 indicates the proportion of infective viruses measured by culturing. B/B0 indicates the proportion of cells with bound viruses,
measured by ﬂow cytometry. (B) Comparison of the binding loss as a function of ClO2 exposure among wild-type (black circles), EA (purple
triangles) and NEA (green squares).
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132, 240, and 259 in the canyon region of VP1. Site 139 was
also highlighted by others, who recognized it to be an
important site for poliovirus interaction with its canyon-binding
receptor PVR.60,61 The E populations described herein also
contain mutations in positions 139 and 259 (G139R in VP2
and K259Q in VP1). Although arginine was already the major
allele in WT at position 139, it became ﬁxed in all the evolved
populations, and therefore is potentially beneﬁcial in our
experimental setup. Additionally, mutations S131N and M238V
in the E populations are situated close to mutations at positions
132 and 240 identiﬁed by Stuart et al. Rezaikin et al.
determined that a mutation at position 129 was related to
altered cell tropism in E11.56 A mutation in this position,
P129Q, was also found in the E populations. Notably, this
mutation also caused the substitution of a ClO2-reactive amino
acid (proline) by a ClO2-stable one (glutamine). This suggests
that this mutation renders the protein capsid more enduring
when exposed to ClO2, which may contribute to the mutant’s
enhanced ability to bind in the presence of ClO2.
NE populations, on the other hand, have only four mutations
on the structural proteins (depicted in SI Figure S4B).
Mutation G139R on VP2 was shared with E populations, and
its role in altering cell receptor use was discussed above.
Mutation H215N is positioned in the binding region of
coxsackievirus B3 with its canyon-binding receptor.62 Strauss et
al. observed a conformational change in the corresponding site
of poliovirus when the virus bound to the canyon-binding
receptor PVR.60 This suggests that position 215 on VP1 is
linked to usage of a canyon-binding receptor in other
enteroviruses, and E11 may also exploit this alternative. Finally,
this mutation, along with mutation Y160F, substitute ClO2-
labile by ClO2-stable amino acid residues, thereby enhancing
the chemical capsid stability of the NE populations compared
to WT.
Experimental Evidence for Alternative Receptor Use
by Resistant Populations. To experimentally conﬁrm that
ClO2-resistance altered the receptor use of populations E and
NE, the binding ability of the diﬀerent virus populations to
BGMK cells was quantiﬁed while partly blocking cellular
receptor DAF by anti-DAF antibodies. Results showed that all
the viruses bound equally well to BGMK cells in the absence of
anti-DAF antibodies (Figure 4A and SI Figure S2). This result
was anticipated because the mutations identiﬁed on the viral
structural protein were not located within binding sites to DAF,
and hence the interaction between virus and this receptor was
not aﬀected. However, when anti-DAF antibodies were added
and DAF was less accessible, mutant populations still
successfully bound to BGMK, whereas the proportion of
virus-bound cells decreased signiﬁcantly for WT populations (p
= 0.0008; Figure 4B and SI Figure S3).
The eﬀect of the anti-DAF antibody was conﬁrmed by
comparing growth curves of each virus with or without addition
of the antibody (SI Figure S5 and Table S4). With the antibody
added, the exponential phase growth rate of WT decreased to
42% of its original value, while EA and NEA retained 71% and
59% of their original growth rate, respectively. The ﬁnal virus
concentration also decreased to 3% of the original concen-
tration for WT, compared to a smaller decrease in EA (10%)
and no ﬁnal titer decrease in NEA.
Finally, changes in receptor use were also supported by
testing the virus’ susceptibility to pleconaril. This antipicorna-
virus drug induces a conformational change in the ﬂoor of the
canyon, which in turn blocks receptor binding and/or the
uncoating process.63 The growth of EA and NEA was
completely inhibited in the presence of 1.3 μM pleconaril (SI
Figure S6A and B), while WT increased in titer after 12 h of
incubation with host cells (SI Figure S6B). Two possible
explanations can be invoked to explain these results. First, as
discussed above, E and NE may use the canyon as a binding
motif, and hence may be more strongly aﬀected by a drug
aﬀecting the canyon conﬁrmation. Alternatively, the mutant
populations may have stronger interactions with pleconaril
compared to the WT. Interestingly, previous studies on the
eﬀect of pleconaril on enteroviruses, including E11, showed
that the presence of valine in the hydrophobic pocket region of
the canyon was associated with increased pleconaril suscept-
ibility, whereas methionine impeded pleconaril insertion.64−66
This is thus consistent with the mutation M238V of E
populations rendering them more susceptible to pleconaril.
Combined, these results are consistent with the hypothesis
that the ClO2-resistant mutants developed the capacity to
better utilize an alternative canyon-binding cellular receptor
compared to the WT, which ultimately allowed them to better
bind to host cells after treatment by ClO2.
Entry Routes Altered by ClO2-Resistance. Besides
altering cellular receptor requirements, the mutations in E
and NE may change viral entry routes, which are linked to
receptor use.67,68 Here, we used a suite of drugs that inhibit
diﬀerent cellular factors linked to endocytosis (SI Table S5), to
identify if ClO2 resistance altered the role of these endocytosis
markers. Speciﬁcally, diﬀerent entry steps in WT and mutants
were probed using nystatin, chlorpromazine, cytochalasin D,
nocodazole, and rottlerin (SI Table S5). Nystatin sequesters
choresterol and thus targets the caveolin-mediated entry route,
which involves cholesterol rich membranes.33,69 Nystatin did
not have any eﬀect on cell infection and growth of WT, but
Figure 4. Comparison of the binding eﬃciency of the wild-type and the mutant populations EA and NEA on BGMK cells (A) in the absence and
(B) in the presence of anti-DAF antibodies. The results are presented as the percentage of virus-positive cells measured by ﬂow cytometry. The error
bars represent the range of two replicates.
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reduced the production of E and NE (Figure 5). This indicates
that WT does not enter cells by a caveolae-mediated route,
whereas this entry route was employed by E and NE. The
clathrin-mediated entry route is inhibited by chlorpromazine,
which prevents the assembly of clathrin lattices.30 Chlorpro-
mazine inhibited all viruses, though the eﬀect on the ClO2-
resistant populations was more prominent. Therefore, clathrin-
mediated entry might be a minor route for WT whereas the
mutants rely more heavily on this route. Cytochalasin D
inhibits actin polymerization and, as such, could have an eﬀect
on all the membrane traﬃcking routes as well as macro-
pinocytosis.70,71 At the added concentrations, cytochalasin D
aﬀected the resistant viruses to a seemingly greater extent than
the WT though the diﬀerence was not statistically signiﬁcant (p
= 0.078). Hence the infection of BGMK cells by WT may be
less dependent on intact actin, and WT may be less likely to use
macropinocytosis as the entry route. The lack of importance of
macropinocytosis in the WT was further supported by
experiments using rottlerin. Rottlerin inhibits protein kinase
C (PKC), which is a stimulant of micropinocytosis.32
Production of WT was not aﬀected by rottlerin, indicating
that disruption of the macropinocytosis entry route was
irrelevant for infection by WT. In contrast, both mutants had
more than 90% reduction in growth in the presence of the drug.
Thus, entry of the mutants are PKC dependent. Upla et al.
suggested that PKC activity is needed for the signaling pathway
induced by echovirus binding to α2β1 integrin.72 As proposed
above, the mutants potentially use a canyon-binding receptor
such as α2β1. The importance of PKC for the mutants but not
WT may thus be linked to signaling from α2β1 binding. Finally,
upon entry, nocodazole disrupts microtubules that are
considered vital for the travel of endosomes to the perinuclear
region.73 Microtubules were vital for successful infection of
BGMK cells by the mutants, while WT was only aﬀected to a
minor extent. Therefore, WT E11 has a transport system that
does not rely on microtubules.
Overall, these results demonstrate multiple eﬀects of
resistance development on E11 entry routes. While these
changes may be neutral and not directly involved in the
mechanism of resistance, they indicate profound alteration of
the viral life cycle.
Eﬀect of Resistance on Replicative Fitness. Arguably
the most relevant question related to disinfection resistance is
whether the resistant mutants can compete with or even
outcompete the WT. We therefore tested the ﬁtness of the
resistant populations individually and in direct competition
with the WT. When each virus population was individually
grown on BGMK cells, no signiﬁcant diﬀerence was observed in
their growth rate, ﬁnal titer or genome copy number (SI Figure
S7). All virus populations were thus equally ﬁt if grown
individually. However, if WT and mutant viruses were
coinfected at a 1:1 ratio, the resistant viruses dominated the
population after 72 h of growth (SI Figure S8). Similar
experiments were repeated in Caco-2, Vero and A549 cell lines
(data not shown). With the only exception of Vero cells, where
mutant NE populations were equally ﬁt as WT, E and NE were
consistently ﬁtter than WT. These results indicate that the
ﬁtness advantage of the ClO2-resistant mutants is not speciﬁc to
the host cell that they are adapted to. Instead, under our
experimental conditions the mutants could outcompete WT in
all cell lines tested.
The ﬁnding of greater ﬁtness in the evolved populations
raises the question of why the associated genetic changes are
not already present in the starting population (WT), and if the
relevant mutations are encountered in naturally occurring
enteroviruses. Compared to experimental evolution, conditions
encountered in virus evolution during natural circulation are
considerably more complex, and involve both virus trans-
mission via the environment and from person-to-person.
Therefore, the beneﬁcial mutations that emerged during
experimental evolution may be neutral or even detrimental in
the natural environment. Interestingly, a nucleotide BLAST
analysis of VP1 revealed that all of the mutations identiﬁed in
VP1 have previously been reported in clinical or sewage isolates
of E11 (SI Table S6). Two mutations C2844A and T2849A
were present in more than 98% of the 487 full VP1 sequences
included. The other mutations were present at 0.4% to 44.6%.
Similarly, a BLAST analysis of VP2, VP3 and 3Dpol, the other
proteins with nonsynonymous mutations, revealed previous
reports of all but one mutation (C6006T) as well. This
indicates that most nonsynonymous mutations identiﬁed here
are neutral or even beneﬁcial to actual virus circulation, even if
they were not acquired by the WT used herein. Ultimately, this
implies that viruses with ClO2 resistance may successfully
circulate.
Implications for Virus Disinfection Practice. This work
demonstrates that ClO2-resistant populations of a human
pathogenic virus, E11, can emerge as a result of frequent
expansion from low population numbers. To date, it remains
unclear if resistance develops during natural virus circulation,
given that a virus’ natural environment is a more complex
system involving selection by more diverse stressors compared
to the in vitro system considered herein. Even if it evolved
naturally, however, resistance may go undetected, as outbreaks
of waterborne viral disease are diﬃcult to capture, and because
even in the resistant viruses some disinfection susceptibility
remains. Nevertheless, this study suggests that viruses can exist
that challenge current disinfection practices. Speciﬁcally, the US
EPA currently suggests a ClO2 dose of 33.4 mg·min/L to
ensure a 4 log10 inactivation of viruses at 5 °C.
74 At this dose,
the E11 WT would undergo an inactivation of 8 log10, whereas
that of E and NE would only amount to 4 log10. Although the
Figure 5. Eﬀect of various entry inhibitors on infection of BGMK cells
by WT (black), EA (purple) and NEA (green). The number of
genome copies after 12 h of incubation in the presence of a drug
(g_drug+) was determined by qRT-PCR and compared with that in
the drug-free controls (g_drug-). The error bars represent standard
deviations of triplicate experiments. ●: the inhibition eﬀect by adding
the drug is not signiﬁcant (p > 0.05); *: Inhibition in growth is not
signiﬁcantly diﬀerent between WT and mutant (p > 0.05). The
concentrations of the drugs were: Nystatin, 50 μM; Chlorpromazine,
40 μM; Cytochalasin D, 8 μM; Nocodazole, 40 μM; Rottlerin, 10 μM.
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inactivation E and NE still falls within the desired range, the
discrepancy to the inactivation of the WT highlights that
current disinfection protocols and water treatment standards
may need to be adapted to ensure the control of resistant
viruses and limit their proliferation.
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